XML 18 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Total
Common Stock
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Non-controlling Interest [Member]
Beginning Balance at Dec. 31, 2023 $ (85,906,534) $ 2,042 $ 263,616,186 $ (296,096,957) $ (53,427,805)
Beginning Balance, Shares at Dec. 31, 2023   20,420,896      
Share-based compensation 1,564,533 $ 1 1,564,532    
Share-based compensation, Shares   7,277      
Cancellation of stock awards for payment of withholding tax requirements (16,398)   (16,398)    
Director compensation paid in share-based instruments/Stock 246,150   246,150    
Director compensation paid in share-based instruments/stock, Shares   2,953      
Changes in ownership interest in a subsidiary 0        
Fair value of warrants classified as liabilities (7,754,438)   (7,754,438)    
Common stock issued for convertible debt conversion 327,388 $ 6 327,382    
Common stock issued for convertible debt conversion, Shares   55,000      
Common stock issued and exchanged with related party 429,569 $ 10 429,559    
Common stock issued and exchanged with related party, Shares   104,518      
Net income (loss) (2,807,759)     1,970,921 (4,778,680)
Ending Balance at Jun. 30, 2024 (93,917,489) $ 2,059 258,412,973 (294,126,036) (58,206,485)
Ending Balance, Shares at Jun. 30, 2024   20,590,644      
Beginning Balance at Mar. 31, 2024 (91,058,753) $ 2,043 257,542,998 (292,598,933) (56,004,861)
Beginning Balance, Shares at Mar. 31, 2024   20,428,173      
Share-based compensation 101,785   101,785    
Director compensation paid in share-based instruments/Stock 11,250   11,250    
Director compensation paid in share-based instruments/stock, Shares   2,953      
Common stock issued for convertible debt conversion 327,388 $ 6 327,382    
Common stock issued for convertible debt conversion, Shares   55,000      
Common stock issued and exchanged with related party 429,568 $ 10 429,558    
Common stock issued and exchanged with related party, Shares   104,518      
Net income (loss) (3,728,727)     (1,527,103) (2,201,624)
Ending Balance at Jun. 30, 2024 (93,917,489) $ 2,059 258,412,973 (294,126,036) (58,206,485)
Ending Balance, Shares at Jun. 30, 2024   20,590,644      
Beginning Balance at Dec. 31, 2024 (79,083,171) $ 2,883 264,191,579 (280,439,023) (62,838,610)
Beginning Balance, Shares at Dec. 31, 2024   28,825,333      
Share-based compensation 91,484   91,484    
Consultant compensation paid in stock 147,780 $ 26 147,754    
Consultant compensation paid in stock, Shares   261,500      
Director compensation paid in share-based instruments/Stock 17,284 $ 4 17,280    
Director compensation paid in share-based instruments/stock, Shares   36,404      
Equity Exchange in connection with Mexican Corporate Transactions 2,229,557   2,229,557    
Changes in ownership interest in a subsidiary 30,327,887   (30,327,887)   30,327,887
Common stock issued for warrants exercised 1,121,685 $ 46 1,121,639    
Common stock issued for warrants exercised, Shares   460,000      
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs 2,764,618 $ 290 2,764,328    
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs, Shares   2,901,595      
Net income (loss) (17,555,151)     (12,606,393) (4,948,758)
Ending Balance at Jun. 30, 2025 (90,265,914) $ 3,249 240,235,734 (293,045,416) (37,459,481)
Ending Balance, Shares at Jun. 30, 2025   32,484,832      
Beginning Balance at Mar. 31, 2025 (79,443,557) $ 2,917 264,246,813 (278,197,453) (65,495,834)
Beginning Balance, Shares at Mar. 31, 2025   29,161,833      
Share-based compensation 45,742   45,742    
Consultant compensation paid in stock 51,639 $ 22 51,617    
Consultant compensation paid in stock, Shares   225,000      
Director compensation paid in share-based instruments/Stock 14,584 $ 4 14,580    
Director compensation paid in share-based instruments/stock, Shares   36,404      
Equity Exchange in connection with Mexican Corporate Transactions 2,229,557   2,229,557    
Changes in ownership interest in a subsidiary     (30,327,887)   30,327,887
Common stock issued for warrants exercised 1,121,685 $ 46 1,121,639    
Common stock issued for warrants exercised, Shares   460,000      
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs 2,853,933 $ 260 2,853,673    
Common stock issued in connection with Securities Purchase Agreement, net of equity issuance costs, Shares   2,601,595      
Net income (loss) (17,139,497)     (14,847,963) (2,291,534)
Ending Balance at Jun. 30, 2025 $ (90,265,914) $ 3,249 $ 240,235,734 $ (293,045,416) $ (37,459,481)
Ending Balance, Shares at Jun. 30, 2025   32,484,832